Parsons Capital Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.1K | Hold |
|
|||||
|
2025
Q1 | $44.1K | Hold |
|
|||||
|
2024
Q4 | $84.9K | Sell |
|
|||||
|
2024
Q3 | $3.25M | Buy |
|
|||||
|
2024
Q2 | $2.93M | Buy |
|
|||||
|
2024
Q1 | $4.53M | Buy |
|
|||||
|
2023
Q4 | $3.93M | Sell |
|
|||||
|
2023
Q3 | $2.92M | Buy |
|
|||||
|
2023
Q2 | $2.15M | Buy |
|
|||||
|
2023
Q1 | $1.63M | Buy |
|
|||||
|
2022
Q4 | $1.73M | Sell |
|
|||||
|
2022
Q3 | $18.7M | Buy |
|
|||||
|
2022
Q2 | $9.57M | Buy |
|
|||||
|
2022
Q1 | $13.6M | Sell |
|
|||||
|
2021
Q4 | $11.3M | Buy |
|
|||||
|
2021
Q3 | $12.4M | Buy |
|
|||||
|
2021
Q2 | $14.4M | Sell |
|
|||||
|
2021
Q1 | $15.9M | Sell |
|
|||||
|
2020
Q4 | $14.5M | Sell |
|
|||||
|
2020
Q3 | $17.1M | Buy |
|
|||||
|
2020
Q2 | $20.3M | Buy |
|
|||||
|
2020
Q1 | $14.5M | Buy |
|
|||||
|
2019
Q4 | $14.3M | Buy |
|